1.45% -0.0037

Handel nachbörslich: .25 -0.0008 -0.32%

Azitra Inc (AZTR)

Überblick Nachrichten Preisverlauf Forum Prognose

Azitra Inc Aktie (AZTR) Neueste Nachrichten

Azitra Inc (AZTR)

Azitra Inc Aktie (AZTR) Neueste Nachrichten

Azitra Inc Plans Stock Increase at Annual Meeting - TipRanks

Azitra reports safety data from Netherton syndrome treatment trial - Investing.com

Azitra reports safety data from Netherton syndrome treatment trial By Investing.com - Investing.com South Africa

AZTR’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

Azitra Inc Announces Positive Phase 1b Trial Results - TipRanks

Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome - PR Newswire

Azitra (NYSEAMERICAN:AZTR) Stock Price Up 2% – Still a Buy? - Defense World

Azitra Inc (AZTR) Stock: A Year of Market Fluctuations - investchronicle.com

Azitra Reveals Latest Clinical Progress: Two Novel Dermatology Treatments Take Center Stage at BIO 2025 - Stock Titan

Revolutionary Skin Microbiome Treatment Could Help Cancer Patients Stay on Life-Saving Therapy - Stock Titan

FY2025 EPS Estimates for Azitra Lifted by Zacks Small Cap - Defense World

What is Zacks Small Cap’s Forecast for Azitra Q2 Earnings? - Defense World

AZTR: ATR-04 Trial to Dose 1st Patient Mid-2025 - MSN

Azitra (NYSEAMERICAN:AZTR) Trading Up 0.9% – Time to Buy? - Defense World

Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash - Seeking Alpha

Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates - Nasdaq

Azitra Advances Novel Skin Disease Treatments: Key Trial Results Expected in 2025 - Stock Titan

AZTRAzitra Inc Latest Stock News & Market Updates - Stock Titan

Stock Of Azitra Inc (AMEX: AZTR) Jumped By 6.67 Percent Over The Past Month, Is There Room For Upside? - Marketing Sentinel

Azitra Inc (AZTR)’s Day in Review: Closing at 0.30, Down by -6.51 - DWinneX

Azitra Inc (AZTR) Stock: Navigating Drops and Gains - investchronicle.com

Azitra Inc [AZTR] Investment Appeal on the Rise - knoxdaily.com

Azitra Inc (AMEX:AZTR) stock: You might be surprised - uspostnews.com

Stocks of Azitra Inc (AZTR) are poised to climb above their peers - Sete News

Azitra (AZTR) Secures Funding Through $20 Million Share Purchase Agreement - GuruFocus

What to expect from Azitra Inc’s (AZTR) current quarter earnings? - uspostnews.com

AZTR’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

Branford-based biopharma Azitra Inc. gains $20M in partnership deal with Alumni Capital - Hartford Business Journal

Azitra (AZTR) to Highlight Precision Dermatology Advances at Bru - GuruFocus

Market Momentum: Azitra Inc (AZTR) Registers a 3.73 Increase, Closing at 0.31 - DWinneX

Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025 - The Victoria Advocate

Why Coursera Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket - Benzinga

Azitra enters share purchase agreement with Alumni Capital for up to $20M - MSN

Azitra secures funding deal for dermatology treatments By Investing.com - Investing.com India

Azitra secures funding deal for dermatology treatments - Investing.com

$20M Strategic Investment Accelerates Azitra's Breakthrough Treatments for 150,000 Rare Disease Patients - Stock Titan

Azitra (NYSEAMERICAN:AZTR) Trading Up 3.9% – Here’s Why - Defense World

Azitra Announces Proposed Public Offering of Common Stock (PR Newswire) - Aktiellt

Azitra, Inc. (NYSEAMERICAN:AZTR) Shares Acquired by Virtu Financial LLC - Defense World

Teacher Retirement System of Texas Makes New $236,000 Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World

Azitra (AZTR) Expected to Announce Quarterly Earnings on Friday - Defense World

Azitra to Present at Microbiome Times Partnering Forum – Company Announcement - Financial Times

Azitra to Present at Microbiome Times Partnering Forum - PR Newswire

Microbiome Disease Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 140+ Companies and 180+ Therapies | DelveInsight - GlobeNewswire

AZTR: Netherton Topline Expected by Year-End - MSN

Azitra, Inc. (NYSEAMERICAN:AZTR) Short Interest Up 144.1% in February - Defense World

Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates - Citizentribune

Azitra, Inc. Announces FY 2024 Financial Results and Business Updates - Defense World

Maxim Group cuts Azitra stock price target to $2 from $3, retains Buy rating - Investing.com

Maxim Group cuts Azitra stock price target to $2 from $3, retains Buy rating By Investing.com - Investing.com South Africa

Ähnlich wie AZTR